AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM)

CUSIP: 02290A102

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / SPONSORED ADS
Total 13F shares
17,117,833
Share change
-19,016
Total reported value
$45,361,349
Price per share
$2.65
Number of holders
13
Value change
-$54,747
Number of buys
2
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 02290A102?
CUSIP 02290A102 identifies AMAM - AMBRX BIOPHARMA INC - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) as of Q2 2022

As of 30 Jun 2022, AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,117,833 shares. The largest 10 holders included FMR LLC, BlackRock Inc., Cormorant Asset Management, LP, Artal Group S.A., ADAGE CAPITAL PARTNERS GP, L.L.C., Fosun International Ltd, SUVRETTA CAPITAL MANAGEMENT, LLC, Octagon Capital Advisors LP, MILLENNIUM MANAGEMENT LLC, and NORGES BANK. This page lists 13 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.